Skip to main content
Figure 2 | Trials

Figure 2

From: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

Figure 2

Differences in long-term renal survival (end-stage renal disease or death) on the basis of estimated glomerular filtration (eGFR) for patients with ANCA-associated vasculitis enrolled in three randomized trials. Blue line represents patients with an eGFR of ≤ 50 mL/min/1.73 m2; red line represents patients with an eGFR of >50 mL/min/1.73 m2.

Back to article page

Trials

ISSN: 1745-6215